Rohan Ahluwalia

Rohan Ahluwalia practices at Palo Alto Medial Foundation in Santa Cruz, California.

Rohan Ahluwalia's NPI, 1053632356, was assigned on June 21, 2010. Rohan Ahluwalia graduated from Texas a & M University System, Hsc, College of Medicine in 2010. Rohan Ahluwalia holds California license A141525.

Rohan Ahluwalia's primary practice is Palo Alto Medial Foundation, at 2850 Commercial Xing, Santa Cruz, CA 95065-1702. The practice phone is (831) 460-7350.

Rohan Ahluwalia's primary practice is Palo Alto Medial Foundation in Santa Cruz, California. Rohan Ahluwalia is also affiliated with Dignity Health - Dominican Hospital. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Rohan Ahluwalia to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rohan Ahluwalia practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rohan Ahluwalia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Rohan Ahluwalia is licensed in California.

CMS data shows 130,049 Medicare services from Rohan Ahluwalia across 52 procedure codes in 2024, for 953 Medicare patients. Medicare paid $2,470,078 for them. Every service was in an office.

CMS counts 953 Medicare patients who saw Rohan Ahluwalia in 2024. The largest group is 65 to 74, with 401 patients. 68% of them have high cholesterol, and 65% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rohan Ahluwalia's median patient age at 70, with 61% women.

In 2024, Rohan Ahluwalia wrote 1,147 Medicare Part D claims for 203 patients. 76% of them were for generic drugs. CMS names the drug for 996 of them, across 25 drugs with 11 or more claims each, at $3,101,663 in total drug cost. In 2023, CMS named 694 claims across 16 drugs.

Rohan Ahluwalia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rohan Ahluwalia as offering telehealth.

Dmand AI links 3 papers to Rohan Ahluwalia, published from 2013 to 2021. Rohan Ahluwalia's most frequent co-authors are Kenneth Robert Carson, MD, Matthew Walter Jaenicke, MD and Jesse Raia Qualliotine, MD.

CMS Open Payments shows 54 general payments to Rohan Ahluwalia from 29 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Sanofi and Genzyme US Companies paid the most, $241.

Rohan Ahluwalia graduated from Texas a & M University System, Hsc, College of Medicine in 2010.